Understanding inhaler users' perceptions of climate change and inhaler carbon footprints: insights from a Canadian survey. [PDF]
Butler SJ +14 more
europepmc +1 more source
Prescription patterns of inhaler medications from 2017 to 2023: A retrospective study using Ontario administrative healthcare data. [PDF]
Train A +9 more
europepmc +1 more source
Ensuring continued access to essential inhaled respiratory medications: a call to action from the Inhaled Respiratory medicine Innovation and environmental Sustainability (IRIS) group. [PDF]
Hurst JR +11 more
europepmc +1 more source
Advancing sustainable medication use in healthcare: a Delphi study on (de)prescribing interventions. [PDF]
Smale EM +10 more
europepmc +1 more source
A Breath of Fresh Air: Carbon Emissions From Inhaler Devices and the Role of Prescribing Clinicians in Reducing Their Environmental Harm. [PDF]
Ahmed JI.
europepmc +1 more source
Reducing Inhaler Waste and Costs Through Sustainable Interventions. [PDF]
Laguë M +7 more
europepmc +1 more source
A Longitudinal Assessment of Greenhouse Gas Emissions From Inhaler Devices in a National Health System. [PDF]
Weppner WG +4 more
europepmc +1 more source
Fluticasone- vs Budesonide-Based Dual Therapy for COPD.
Feldman WB +6 more
europepmc +1 more source
Inhaler-Related Greenhouse Gas Emissions in the US: A Serial Cross-Sectional Analysis.
Feldman WB +4 more
europepmc +1 more source
Inability of Physicians to Use Metered-Dose Inhalers
The effectiveness of antiasthmatic therapy with metered-dose inhalers (MDIs) is usually limited by defective inhalational technique. This study surveyed the MDI inhalation performance and knowledge of 100 physicians whose performance (demarcated into six stages) and knowledge scores correlated (r = 0.33, p < 0.001).
Kenneth W Tsang, Mary S M Ip, Bing Lam
exaly +5 more sources

